Lv1
10 积分 2025-09-24 加入
Colchicine for recurrent pericarditis—what's new in CORP-2?
6小时前
待确认
Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial
6小时前
已完结
Colchicine for Recurrent Pericarditis (CORP)
6小时前
已完结
Colchicine in Pericarditis
12天前
已完结
Mechanisms of foam cell formation in atherosclerosis
1个月前
已完结
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: A randomized placebo-controlled trial
1个月前
已关闭
Colchicine alleviates atherosclerosis combined with diabetes mellitus by targeting PIM2 and regulating the NF-κB signaling pathway
1个月前
已完结
Macrophage junctional adhesion molecule-like (JAML) protein promotes NLRP3 inflammasome activation in the development of atherosclerosis
1个月前
已完结
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
1个月前
已完结
Effects of imbalance of lipid metabolism through NF-KB pathway on atherosclerosis and vascular aging in rats
2个月前
已完结
皖公网安备34019202002308
